English Español

Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

English Español

Loading

Loading

IVDmap

Global entry platform for product discovery, supplier mapping, and procurement decision support.

Platform

Home
Products
Companies
Technologies
Insights
Tools
Glossary

Buyers

Buyer's Guide
Resource Packs
Request Quote
Case Studies

Partners

Become a Partner
OEM Cooperation
Partner application

Company / Legal

Contact
Privacy
Terms
Disclaimer
[email protected]

Regulatory Notice Disclaimer Privacy TermsFor professional use only. Availability varies by country.

Search IVDmap

Search products, companies, tests, and guides — go from query to quote request in one place.

Search

Showing 1 - 6 of 6 for “CNS Affecting Drug Measurement”

All Results (6)Article (6)

Article

Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan.

Research record from Front Oncol, 2026-07-17. PMID 42539473.

Article

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

Research record from J Natl Compr Canc Netw, 2026-03-31. PMID 41991041.

Article

Clinical utility of CSF metagenomic next-generation sequencing in suspected CNS infection: performance against a composite reference standard and read-count stratification.

Research record from Front Cell Infect Microbiol, 2026-07-28. PMID 42582033.

Article

Epidemiological trends in viral CNS infections in a French university hospital from 2019 to 2024, as revealed by multiplex PCR testing of cerebrospinal fluid samples.

Research record from Int J Infect Dis, 2026-07-12. PMID 42437597.

Article

Globalising the access to advanced molecular diagnostics of CNS tumors: Experience of the Molecular Neuro-Pathology (MNP) Outreach Consortium.

Research record from Neuro Oncol, 2026-10-12. PMID 42861759.

Article

Role of Surrogate Immunohistochemistry Markers in CNS Tumors in the Era of Molecular Diagnostics With Recent Updates.

Research record from Adv Anat Pathol, 2026-04-09. PMID 41954087.